Liraglutide
Saxenda · Victoza · 利拉鲁肽
Think of it as a body double for appetite control.
Liraglutide is like a friendly impersonator of a natural hormone in your body. It sends signals to your brain that make you feel full, even if you haven't eaten much. This makes it easier to reduce your food intake without feeling like you're missing out.
Besides helping with weight management, Liraglutide also plays a role in regulating how your body handles sugar. It nudges your pancreas to release insulin when needed and keeps the liver from overproducing sugar. This can be particularly helpful for those managing their blood sugar levels.
Liraglutide has also shown some heart-friendly benefits, especially for folks with type 2 diabetes who are at a higher risk of heart issues. It's like giving your heart a bit of extra protection while you're working on your weight and sugar levels.
Who it's for
- People struggling with weight management who want to feel less hungry.
- Those managing type 2 diabetes looking for better blood sugar control.
- Individuals at risk of heart issues who need an additional protective measure.
Probably not for you if…
- Anyone uncomfortable with daily injections.
- People looking for an over-the-counter solution.
- Those who aren't managing weight or blood sugar issues.
Editorial summary for research context · Not medical advice
Mechanism of Action
Liraglutide is a daily-injected GLP-1 receptor agonist with ~97% homology to native human GLP-1 and a C16 fatty-acid side chain that enables albumin binding and extends half-life to ~13 hours. It enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite via hypothalamic signaling. FDA-approved for type 2 diabetes (Victoza) and chronic weight management (Saxenda) — only prescribed, pharmaceutical-grade product is appropriate for human use.
Researched Benefits
Weight reduction
SCALE Obesity trial reported mean ~8% weight loss at the 3.0mg daily dose over 56 weeks.
- [Pi-Sunyer et al. 2015]
Glycemic control
LEAD trial series showed HbA1c reductions of ~1.0–1.5 percentage points in type 2 diabetes at the 1.8mg daily dose.
Cardiovascular outcomes
LEADER trial demonstrated reduction in major adverse cardiovascular events in patients with type 2 diabetes at high cardiovascular risk.
- [Marso et al. 2016]
Research Protocols
The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.
Clinical titration (reference only — prescription required)
- Dosage
- 0.6 mg
- Frequency
- once daily
- Timing
- same time each day
- Cycle
- 1 weeks
Clinical trials titrate weekly: 0.6 → 1.2 → 1.8 → 2.4 → 3.0mg daily. Only prescribed use is appropriate.
Reported Side Effects
- Gastrointestinal: nausea, vomiting, diarrhea, constipation (titration-related)
- Injection-site reactions
- Hypoglycemia risk when combined with insulin or sulfonylureas
- Rare: pancreatitis, gallbladder events
- Boxed warning: thyroid C-cell tumor risk observed in rodents
Contraindications
- Personal or family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2
- Pregnancy
- History of pancreatitis
Stacking Partners
Peptides commonly paired with Liraglutide in published research and protocol write-ups.
Vendor Pricing
No tracked vendors carry this peptide yet. Check back as we add more affiliate partners.
Gear + Companions
Reconstitution supplies and research-backed supplement companions for Liraglutide. Editorial picks only — we earn a commission through Amazon on the click, no sponsorship.
Gear you'll need
· Reconstitution + storage essentialsBacteriostatic Water 30mL (0.9% Benzyl Alcohol)
Empower Pharmacy / generic medical supply
Reconstitutes every lyophilized peptide. 28-day viability refrigerated.
Insulin Syringes 31G × 5/16" × 0.5mL (100 count)
EasyTouch
31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.
Alcohol Prep Pads (Sterile, 200 count)
Dynarex
Sterile 70% IPA prep pads — one per vial stopper + one per injection site.
1-Quart Sharps Disposal Container
BD / Becton Dickinson
FDA-cleared sharps container — pharmacies won't accept improvised disposal.
Stacks well with
· Supplement companions — independent evidence, not sponsoredLMNT Electrolyte Drink Mix Variety Pack (30 sticks)
LMNT
GLP-1 agonism suppresses thirst — dehydration + electrolyte drop is the #1 source of the 'GLP-1 flu' complaint. LMNT targets that gap directly.
Psyllium Husk Fiber Capsules (500 ct)
NOW Foods
Constipation is the most-reported GLP-1 side effect. Daily soluble fiber addresses it without blunting the appetite effect.
Whey Protein Isolate 5 lb (Grass-Fed, Unflavored)
NAKED Nutrition
Appetite suppression tanks protein intake if you don't actively defend it — protein powder is the cheapest floor against lean-mass loss.
As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines
Top Videos
Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.
4:41What happens to your body when you stop taking weight-loss drugs l GMA
Good Morning America
434.8K views · 4:41 · 2 years ago
5:36Saxenda: How To Use It Effectively
Dr. Brian Yeung, ND
137.6K views · 5:36 · 5 years ago
4:56Understanding risks of GLP-1 weight loss drugs
Click On Detroit | Local 4 | WDIV
123.1K views · 4:56 · 1 year ago
6:44Ozempic vs Rybelsus vs Saxenda vs Victoza: Comparing Weight Loss Drugs
Dr. Brian Yeung, ND
117.7K views · 6:44 · 4 years ago
7:24Weight Loss Takes How Long on GLP-1? Obesity Doctor
Weight Medicine with Dr. Meghan MD
77.3K views · 7:24 · 1 year ago
Research Papers
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer X, et al. · New England Journal of Medicine · 2015
PubMed 26132939 →Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER)
Marso SP, et al. · New England Journal of Medicine · 2016
PubMed 27295427 →